Matches in SemOpenAlex for { <https://semopenalex.org/work/W4289314211> ?p ?o ?g. }
- W4289314211 endingPage "8541" @default.
- W4289314211 startingPage "8541" @default.
- W4289314211 abstract "Immune-checkpoint inhibitors (ICIs) have increased and improved the treatment options for patients with non-oncogene-addicted advanced stage non-small cell lung cancer (NSCLC). However, the role of ICIs in oncogene-addicted advanced stage NSCLC patients is still debated. In this study, in an attempt to fill in the informational gap on the effect of ICIs on other driver mutations, we set out to provide a molecular landscape of clinically relevant oncogenic drivers in programmed death-ligand 1 (PD-L1) positive NSCLC patients.We retrospectively reviewed data on 167 advanced stage NSCLC PD-L1 positive patients (≥1%) who were referred to our clinic for molecular evaluation of five driver oncogenes, namely, EGFR, KRAS, BRAF, ALK and ROS1.Interestingly, n = 93 (55.7%) patients showed at least one genomic alteration within the tested genes. Furthermore, analyzing a subset of patients with PD-L1 tumor proportion score (TPS) ≥ 50% and concomitant gene alterations (n = 8), we found that n = 3 (37.5%) of these patients feature clinical benefit with ICIs administration, despite the presence of a concomitant KRAS gene alteration.In this study, we provide a molecular landscape of clinically relevant biomarkers in NSCLC PD-L1 positive patients, along with data evidencing the clinical benefit of ICIs in patient NSCLC PD-L1 positive alterations." @default.
- W4289314211 created "2022-08-02" @default.
- W4289314211 creator A5008742164 @default.
- W4289314211 creator A5016180101 @default.
- W4289314211 creator A5017669867 @default.
- W4289314211 creator A5020212690 @default.
- W4289314211 creator A5020499018 @default.
- W4289314211 creator A5025117598 @default.
- W4289314211 creator A5029462273 @default.
- W4289314211 creator A5029922900 @default.
- W4289314211 creator A5032330087 @default.
- W4289314211 creator A5033454821 @default.
- W4289314211 creator A5036143430 @default.
- W4289314211 creator A5037705070 @default.
- W4289314211 creator A5040413764 @default.
- W4289314211 creator A5042437246 @default.
- W4289314211 creator A5042872767 @default.
- W4289314211 creator A5045115021 @default.
- W4289314211 creator A5045384053 @default.
- W4289314211 creator A5047502130 @default.
- W4289314211 creator A5048743157 @default.
- W4289314211 creator A5050306229 @default.
- W4289314211 creator A5051072215 @default.
- W4289314211 creator A5061222063 @default.
- W4289314211 creator A5063245891 @default.
- W4289314211 creator A5065532659 @default.
- W4289314211 creator A5066360448 @default.
- W4289314211 creator A5071102498 @default.
- W4289314211 creator A5075073321 @default.
- W4289314211 creator A5089411528 @default.
- W4289314211 creator A5089708524 @default.
- W4289314211 date "2022-08-01" @default.
- W4289314211 modified "2023-10-15" @default.
- W4289314211 title "Evaluation of the Molecular Landscape in PD-L1 Positive Metastatic NSCLC: Data from Campania, Italy" @default.
- W4289314211 cites W1974903221 @default.
- W4289314211 cites W1990626198 @default.
- W4289314211 cites W2050249255 @default.
- W4289314211 cites W2111662961 @default.
- W4289314211 cites W2132870547 @default.
- W4289314211 cites W2137611437 @default.
- W4289314211 cites W2166084034 @default.
- W4289314211 cites W2251438188 @default.
- W4289314211 cites W2322472460 @default.
- W4289314211 cites W2400514548 @default.
- W4289314211 cites W2409383155 @default.
- W4289314211 cites W2509197720 @default.
- W4289314211 cites W2510040899 @default.
- W4289314211 cites W2512256185 @default.
- W4289314211 cites W2527905628 @default.
- W4289314211 cites W2552750859 @default.
- W4289314211 cites W2557730509 @default.
- W4289314211 cites W2561459036 @default.
- W4289314211 cites W2578528809 @default.
- W4289314211 cites W2586921464 @default.
- W4289314211 cites W2608102145 @default.
- W4289314211 cites W2624310346 @default.
- W4289314211 cites W2625684877 @default.
- W4289314211 cites W2737532239 @default.
- W4289314211 cites W2770828094 @default.
- W4289314211 cites W2777461561 @default.
- W4289314211 cites W2791290180 @default.
- W4289314211 cites W2796582438 @default.
- W4289314211 cites W2802395274 @default.
- W4289314211 cites W2804050059 @default.
- W4289314211 cites W2804957255 @default.
- W4289314211 cites W2805354595 @default.
- W4289314211 cites W2883867140 @default.
- W4289314211 cites W2889307896 @default.
- W4289314211 cites W2889653218 @default.
- W4289314211 cites W2890894948 @default.
- W4289314211 cites W2894476389 @default.
- W4289314211 cites W2895076725 @default.
- W4289314211 cites W2920766288 @default.
- W4289314211 cites W2925446385 @default.
- W4289314211 cites W2937117858 @default.
- W4289314211 cites W2946166987 @default.
- W4289314211 cites W2946386783 @default.
- W4289314211 cites W2957692095 @default.
- W4289314211 cites W2964192461 @default.
- W4289314211 cites W2982198358 @default.
- W4289314211 cites W2982602983 @default.
- W4289314211 cites W2995220921 @default.
- W4289314211 cites W2995281612 @default.
- W4289314211 cites W2998844423 @default.
- W4289314211 cites W3000445801 @default.
- W4289314211 cites W3003015741 @default.
- W4289314211 cites W3017942271 @default.
- W4289314211 cites W3032221072 @default.
- W4289314211 cites W3094579163 @default.
- W4289314211 cites W3101089668 @default.
- W4289314211 cites W3120836426 @default.
- W4289314211 cites W3127314605 @default.
- W4289314211 cites W3134085098 @default.
- W4289314211 cites W3139391091 @default.
- W4289314211 cites W3164126191 @default.
- W4289314211 cites W3172081492 @default.
- W4289314211 cites W3215921195 @default.
- W4289314211 cites W4206841660 @default.